Kolexia
Roth Gael Gastro-entérologie
Roth Gael
Gastro-entérologie
Hôpital Nord Grenoble
La Tronche, France
140 Activités
319 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Adénocarcinome Fibrose Cholangiocarcinome Tumeurs colorectales Cirrhose du foie Tumeurs des canaux biliaires

Collaborateurs

Voir plus
Decaens Thomas
Decaens Thomas
Hôpital Nord Grenoble, La Tronche, France
Brusset Bleuenn
Brusset Bleuenn
Hôpital Nord Grenoble, La Tronche, France
Artru Pascal
Artru Pascal
Hopital Prive De L'est Lyonnais (hpel), Saint-Priest, France
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France

Industries

Voir plus
Servier
14 collaboration(s)
Dernière en 2023
Ipsen
12 collaboration(s)
Dernière en 2021
MSD
11 collaboration(s)
Dernière en 2023
AstraZeneca
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LAP-NET1: Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
Essai Clinique (NETRIS Pharma)   07 mars 2024
Liver-NET1: Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable Hepatocellular Carcinoma
Essai Clinique (NETRIS Pharma)   07 mars 2024
CRC-ORGA2: Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms: a Patient-derived Tumoroids Prospective Collection From Systemic Treatment Naive Tumors
Essai Clinique (CHU Grenoble)   05 mars 2024
HERIZON-GEA-01: A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
Essai Clinique (Jazz Pharmaceuticals)   04 mars 2024
Oncologie – Arrivée des anti-PD1/PD-L1 dans les tumeurs oesogastriques avec surexpression de HER2
Edimark   29 février 2024
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.
Cell discovery   31 janvier 2024
CAPANCOVID-19: Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer
Essai Clinique (CHU Reims)   23 janvier 2024
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   17 janvier 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024